Preparation of pet precursor

Patent metadata

Field	Value
Publication number	US-9278916-B2
Application number	US-201113989527-A
Country	US
Kind code	B2
Filing date	Nov 28, 2011
Priority date	Nov 29, 2010
Publication date	Mar 8, 2016
Grant date	Mar 8, 2016

Abstract

The invention relates to a process for preparation of radiopharmaceutical precursors, and in particular protected amino acid derivatives which are used as precursors for production of radiolabeled amino acids for use in in vivo imaging procedures such as positron emission tomography (PET). Particularly, the invention relates to a process for preparation of a precursor of the [ 18 F]-1-amino-3-fluorocyclobutanecarboxylic acid ([ 18 F] FACBC) PET agent and particularly to the work-up process of this precursor removing generated salts from the intermediate composition.

First claim

What is claimed is:

1. A process for preparing a compound of formula IIIa:

wherein:
R denotes an alkyl group with 1 to 5 carbon atoms;
X denotes a protecting group for an alcohol;
Y denotes a protecting group for an amine, and
wherein the process comprises a work-up process comprising the steps of:
i) providing at least 100 grams of a crude reaction product comprising said compound of formula IIIa and salts;
ii) adding ethyl acetate to the crude reaction product of step i) to prepare a suspension;
iii) adding a liquid that consists of water to the suspension of step ii) to form a biphasic system comprising an aqueous phase containing the salts, and an organic phase, and discarding the aqueous phase and the salts;
iv) adding an acid to the organic phase of step iii) to form a biphasic system comprising an acidic aqueous phase and an organic phase, and discarding the acidic aqueous phase;
v) washing the organic phase of step iv) with water.

2. A process as claimed in claim 1 wherein X is benzyl.

3. A process as claimed in claim 1 wherein R is ethyl.

4. A process as claimed in claim 1 wherein Y is tert-butyl carbamate (Boc).

5. A process as claimed in claim 1 wherein in step ii) the amount of ethyl acetate added compared to the amount of a starting material comprising a compound of formula IIa:

wherein X and R are defined as in claim 1 ;
is between 15:1 and 25:1 in volume/weight %.

6. A process as claimed in claim 1 wherein in step iii) the amount of water added is about half the amount of ethyl acetate added in step ii).

7. A process as claimed in claim 1 wherein in step iv) the acid added is HCl.

8. A process as claimed in claim 1 wherein in step v) the washing with water is followed by several steps of washing including washing with an aqueous solution of sodium hydrogen carbonate, optionally washing with water again, and washing with brine.

9. A process as claimed in claim 1 further including the steps of concentrating the composition from step iv) under reduced pressure, drying and purifying.

10. A process as claimed in claim 1 wherein the crude reaction product includes a mixture of the syn- and anti-enantiomer of the compound of formula IIIa.

11. A process for preparing the compound of formula Va:

wherein Y is as defined in claim 1 and R is as defined in claim 1 , and LG is a leaving group; wherein said process comprises preparing the compound of formula IIIa according to the process of claim 1 .

12. A process as defined in claim 11 wherein said leaving group is a halogen substituent or a group represented by —OR 2 wherein R 2 is either a fluorosulfonic acid substituent or an aromatic sulfonic acid substituent.

13. A process as defined in claim 12 wherein said leaving group is selected from a toluenesulfonic acid substituent, a nitrobenzenesulfonic acid substituent, a benzenesulfonic acid substituent, a trifluoromethanesulfonic acid substituent, a fluorosulfonic acid substituent, or a perfluoroalkylsulfonic acid substituent.

14. A process as defined in claim 11 wherein said compound of formula Va is a compound of formula V:

15. A process for preparing a compound of formula VI:

wherein said process comprises preparing the compound of formula IIIa according to the process as defined in claim 1 wherein Y is as defined in claim 1 .

Assignees

• Berg Tom Christian
• Nilsen Anne
• Ge Healthcare Ltd

Inventors

• Berg Tom Christian
• Nilsen Anne

Classifications

• C07C269/04 Primary

  from amines with formation of carbamate groups · CPC title

• C07C2101/04

  Chemistry & Metallurgy · mapped topic

• C07C271/24

  with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring · CPC title

• C07B59/001 Primary

  Acyclic or carbocyclic compounds · CPC title

• C07C269/08

  Separation; Purification; Stabilisation; Use of additives · CPC title